Innovotech Inc
XTSX:IOT

Watchlist Manager
Innovotech Inc Logo
Innovotech Inc
XTSX:IOT
Watchlist
Price: 0.27 CAD 8% Market Closed
Market Cap: CA$14.2m

Net Margin

8.6%
Current
Improving
by 16%
vs 3-y average of -7.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.6%
=
Net Income
CA$383.4k
/
Revenue
CA$4.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.6%
=
Net Income
CA$383.4k
/
Revenue
CA$4.5m

Peer Comparison

Country Company Market Cap Net
Margin
CA
Innovotech Inc
XTSX:IOT
14m CAD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Higher than 75% of companies in Canada
Percentile
75th
Based on 4 909 companies
75th percentile
8.6%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Innovotech Inc
Glance View

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.

IOT Intrinsic Value
0.22 CAD
Overvaluation 18%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
8.6%
=
Net Income
CA$383.4k
/
Revenue
CA$4.5m
What is Innovotech Inc's current Net Margin?

The current Net Margin for Innovotech Inc is 8.6%, which is above its 3-year median of -7.4%.

How has Net Margin changed over time?

Over the last 3 years, Innovotech Inc’s Net Margin has decreased from 11.2% to 8.6%. During this period, it reached a low of -29.7% on Jun 30, 2024 and a high of 12.9% on Mar 31, 2025.

Back to Top